Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT00025168
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced, unresectable pancreatic cancer.

Key Dates

Start date
Nov 1, 2001
Status verified
Sep 2021
Primary completion
Aug 29, 2003
Completion
Aug 29, 2003

Study Design

Enrollment
20 participants (actual)
Primary purpose
TREATMENT

Locations (7)

FacilityCityStateZIPSite coordinators
Lineberger Comprehensive Cancer Center, UNCChapel HillNorth Carolina27599-7295-
Southeastern Medical Oncology CenterGoldsboroNorth Carolina27534-
East Carolina University School of MedicineGreenvilleNorth Carolina27858-4354-
Comprehensive Cancer Center at Wake Forest UniversityWinston-SalemNorth Carolina27157-1082-
Hollings Cancer Center at Medical University of South CarolinaCharlestonSouth Carolina29425-
Greenville Hospital SystemGreenvilleSouth Carolina29605-
Spartanburg Regional Healthcare SystemSpartanburgSouth Carolina29303-

Find similar trials in Chapel Hill, NC

By condition

Related Studies